BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2000

View Archived Issues

Promising initial results for Synvisc in osteoarthritis of the hip

Read More

Chiron reports new durable response data for Proleukin

Read More

NR2B NMDA receptor antagonist shows antiparkinsonian activity

Read More

MacroChem to begin phase III home trial of Topiglan

Read More

Different rifalazil regimens examined against M. tuberculosis in mice

Read More

Bristol-Myers Squibb and 3-D form alliance

Read More

Potential new antipsychotic agent presented by Servier at CINP Congress

Read More

Nootropic profile and mechanisms of action of (-)-clausenamide undergo investigation

Read More

Draxis initiates phase I study for new imaging agent for heart attacks

Read More

Dietary restriction protects against neurodegeneration by enhancing neurotrophic factor signaling

Read More

La Jolla Pharmaceutical chooses candidate for blood clotting disorder

Read More

Indian herbal preparation: evidence of efficacy in subjects with age-related cognitive decline

Read More

Cambridge NeuroScience licenses neuregulin-2 from Harvard

Read More

Imidazolidinone antipsychotic agent from Servier interacts with NMDA receptors at the glycine B site

Read More

KS Biomedix acquires antigen/antibody for ulcerative colitis

Read More

Arthritis Advisory Committee recommends new approval for Remicade

Read More

CART technology identifies selective 5-HT2A inverse agonist and putative atypical antipsychotic

Read More

Reminyl completes E.U. mutual recognition procedure

Read More

Humanized MAbs that neutralize interferon gamma described by PDL

Read More

Metabolic disorder collaboration between BMS and Karo Bio extended

Read More

Neuron-associated proteins discovered by Incyte, covered by recent patent

Read More

Centaur's new antiinflammatory agents reportedly act by inhibiting COX-2 induction

Read More

Noncytotoxic immunosuppressive agent discovered by Sankyo in Streptomyces culture

Read More

New compounds interacting with NPY receptors useful for eating disorders, etc.

Read More

Tetrapeptide inhibitors of caspase 3 discovered by Merck Frosst

Read More

Production and use of new AChR modulators reported by NeuroSearch

Read More

New series of psoralen-based photochemotherapeutics claimed by Buckman Laboratories

Read More

Dual alpha2-adrenoceptor blockers/monoamine reuptake inhibitors designed at ADIR

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing